Literature DB >> 28002639

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.

G C Bell1, K E Caudle2, M Whirl-Carrillo3, R J Gordon4, K Hikino5, C A Prows6, A Gaedigk7, Jag Agundez8,9, S Sadhasivam10,11, T E Klein3, M Schwab12,13,14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28002639      PMCID： PMC5479760          DOI： 10.1002/cpt.598

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  26 in total

1.  Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.

Authors:  Myo-Kyoung Kim; Joo-Youn Cho; Hyeong-Seok Lim; Kyoung-Seop Hong; Jae-Yong Chung; Kyun-Seop Bae; Dal-Seok Oh; Sang-Goo Shin; Sang-Hun Lee; Dong-Ho Lee; Bumchan Min; In-Jin Jang
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

2.  CYP1A1 is a major enzyme responsible for the metabolism of granisetron in human liver microsomes.

Authors:  H Nakamura; N Ariyoshi; K Okada; H Nakasa; K Nakazawa; M Kitada
Journal:  Curr Drug Metab       Date:  2005-10       Impact factor: 3.731

3.  Developmental changes in human liver CYP2D6 expression.

Authors:  Jeffrey C Stevens; Sandra A Marsh; Matthew J Zaya; Karen J Regina; Karthika Divakaran; Min Le; Ronald N Hines
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

Review 4.  Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

Authors:  Rebecca L Andersen; Daniel J Johnson; Jai N Patel
Journal:  Pharmacogenomics       Date:  2016-02-12       Impact factor: 2.533

5.  The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?

Authors:  Keith A Candiotti; David J Birnbach; David A Lubarsky; Fani Nhuch; Aimee Kamat; Walter H Koch; Michele Nikoloff; Lin Wu; David Andrews
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

6.  CYP2D6- and CYP3A-dependent enantioselective plasma concentrations of ondansetron in postanesthesia care.

Authors:  Ulrike M Stamer; Eun-Hae Lee; Neele I Rauers; Lan Zhang; Maren Kleine-Brueggeney; Rolf Fimmers; Frank Stuber; Frank Musshoff
Journal:  Anesth Analg       Date:  2011-05-19       Impact factor: 5.108

7.  Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.

Authors:  Rolf Kaiser; Orhan Sezer; Anja Papies; Steffen Bauer; Claudia Schelenz; Pierre-Benoit Tremblay; Kurt Possinger; Ivar Roots; Jürgen Brockmöller
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544

Review 8.  Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Authors:  K R Crews; A Gaedigk; H M Dunnenberger; J S Leeder; T E Klein; K E Caudle; C E Haidar; D D Shen; J T Callaghan; S Sadhasivam; C A Prows; E D Kharasch; T C Skaar
Journal:  Clin Pharmacol Ther       Date:  2014-01-23       Impact factor: 6.875

9.  The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.

Authors:  Takeshi Kadokura; Martin den Adel; Walter J J Krauwinkel; Tetsuo Takeshige; Akito Nishida
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 3.064

10.  Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study.

Authors:  Amalia S Lehmann; Jamie L Renbarger; Catherine L McCormick; Ariel R Topletz; Carrie Rouse; David M Haas
Journal:  BMC Pregnancy Childbirth       Date:  2013-06-20       Impact factor: 3.007
View more
  62 in total

1.  Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.

Authors:  Rachel Huddart; Alison E Fohner; Michelle Whirl-Carrillo; Genevieve L Wojcik; Christopher R Gignoux; Alice B Popejoy; Carlos D Bustamante; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

Review 2.  Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.

Authors:  Jacob T Brown; Jeffrey R Bishop; Katrin Sangkuhl; Erika L Nurmi; Daniel J Mueller; Jean C Dinh; Andrea Gaedigk; Teri E Klein; Kelly E Caudle; James T McCracken; Jose de Leon; J Steven Leeder
Journal:  Clin Pharmacol Ther       Date:  2019-04-13       Impact factor: 6.875

Review 3.  Value of Supportive Care Pharmacogenomics in Oncology Practice.

Authors:  Jai N Patel; Lauren A Wiebe; Henry M Dunnenberger; Howard L McLeod
Journal:  Oncologist       Date:  2018-04-05

4.  Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

Authors:  Wanqiong Qiao; Suparna Martis; Geetu Mendiratta; Lisong Shi; Mariana R Botton; Yao Yang; Andrea Gaedigk; Raymon Vijzelaar; Lisa Edelmann; Ruth Kornreich; Robert J Desnick; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2018-12-06       Impact factor: 2.533

5.  Potentially actionable pharmacogenetic variants and symptom control medications in oncology.

Authors:  Jai N Patel; Danielle Boselli; Elizabeth J Jandrisevits; Issam S Hamadeh; Ahmed Salem; Patrick Meadors; Declan Walsh
Journal:  Support Care Cancer       Date:  2021-03-24       Impact factor: 3.603

Review 6.  Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.

Authors:  Yao Yang; Mariana R Botton; Erick R Scott; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

7.  CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Authors:  Wing Chan; Man S Li; Senthil K Sundaram; Brian Tomlinson; Pik Y Cheung; Chi H Tzang
Journal:  J Clin Lab Anal       Date:  2018-08-01       Impact factor: 2.352

8.  How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.

Authors:  Richard J Marrero; Emily J Cicali; Meghan J Arwood; Elizabeth Eddy; David DeRemer; Brian H Ramnaraign; Karen C Daily; Dennie Jones; Kelsey J Cook; Larisa H Cavallari; Kristin Wiisanen Weitzel; Taimour Langaee; Kimberly J Newsom; Petr Starostik; Michael J Clare-Salzer; Julie A Johnson; Thomas J George; Rhonda M Cooper-DeHoff
Journal:  Clin Pharmacol Ther       Date:  2020-07-06       Impact factor: 6.875

Review 9.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

Review 10.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.